Navigation Links
First Ultrasound Thrombolysis in U.S. Performed at Emory University Hospital

Physicians at Emory University Hospital recently performed for the first time in the United States a procedure called Ultrasound Assisted Thrombolysis to destroy a deadly blood clot in a patient suffering from deep vein thrombosis.

The procedure was performed by Abbas Chamsuddin, MD, associate professor of interventional radiology in the Emory University School of Medicine, to relieve a major system of clotting that filled the veins of the patient's leg, pelvis and inferior vena cava leading up to the heart.

Deep vein thrombosis (DVT) is a blood clot in a deep vein, usually found in the legs. These clots can, in turn, form in superficial veins in deep veins. While blood clots in superficial veins rarely cause serious problems, clots in deep veins (deep vein thrombosis) require immediate medical care.

According to Dr. Chamsuddin, ultrasound assisted thrombolysis incorporates use of a tiny catheter that houses an ultrasound wire and medications which slowly dissolve the clots.

"Ultrasound assisted thrombolysis uses a catheter that houses an ultrasound wire which causes fragmentation of the clot, while dripping clot busting medications are then delivered," says Dr. Chamsuddin."

The catheter-based drug delivery system combines the use of targeted drug delivery catheters and the therapeutic benefits of a high frequency low power ultrasound. The incorporation of ultrasound, says Dr. Chamsuddin, allows physicians to loosen tightly knit fabrics found within a blood clot called fibrin.

"The ultrasound helps temporarily loosen and separate the fibrin for more blood clot permeability," explains Dr. Chamsuddin. "The loosened fibrins then allow for reception of the infusion of clot-busting medications, which then slowly dissolve the blockage - usually within two to three days."

Emory houses two of the machines that are used for this procedure (called Peripheral Infusion Systems). < br>
Other treatments for deep vein clots typically include use of blood thinners such as heparin and warfarin. Heparin is given through a vein (intravenously, or IV) or as an injection. Warfarin is given as a pill. Treatment usually involves taking blood thinners for at least three months to prevent existing clots from growing.


'"/>




Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. First human clone is near
4. First Artificial Heart patient has Major setback
5. First head-to-head trials of once weekly Fosamax and Actonel therapies
6. WHO Declares Vietnam First Country to Control SARS
7. Russia Reports First SARS Case
8. Hope for First New Melanoma Treatment in Decades
9. First global SARS meet opens
10. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
11. Hyderabad To Have Asia’s First Catheter Making Uni
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... ... New patients who want to experience the benefits of dental implants ... by Dr. Manju Kejriwal, with or without a referral. Dr. Kejriwal is a respected ... each dental implant placement. The i-CAT CBCT system captures the shapes of oral structures ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... gain site attention and engagement over the household brands of Top-20 pharma by ... will discuss how partnering with the right outsourcing payments provider can provide the ...
(Date:3/27/2017)... ... March 27, 2017 , ... A study by the founder of the ... Sudeep Roy, MD, was recently published in the American Journal of Cosmetic Surgery. “The ... Buckingham and Roy’s study on the use of Electro Lube during the facelift procedure. ...
(Date:3/27/2017)... ... March 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s CEO ... Runway Foundation and UBS’ Project Entrepreneur. Mayo will present her pitch about the lifestyle ... Project Entrepreneur’s second annual venture competition ignites bold ideas by providing women access to ...
(Date:3/27/2017)... ... March 27, 2017 , ... M&S Technologies, the first name ... the Smart System® 20/20. CE Certification builds upon M&S's long-standing commitment to products ... as ANSI, ISO and proven test methods used in the field of Vision ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017  A new survey from the ... Competitive Bidding Program (CBP) significantly reduced beneficiary choice and ... of choice forces beneficiaries to switch to unfamiliar or ... AADE,s survey is the latest in ... pointing out the inherent problems with the CBP. Last ...
(Date:3/27/2017)... /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or ... is pleased to announce it has received conditional approval ... TSX Venture Exchange.  Receiving the conditional ... significant achievements for Invictus-MD. Some of which include: ... Laboratories Inc. ("AB Labs"), a Licensed Producer under the ...
(Date:3/27/2017)... , March 27, 2017 ... as the NASDAQ Composite closed the trading session up ... and the S&P 500 was down 0.08%. US markets ... sectors finishing the day in green. Pre-market today, Stock-Callers.com ... Medical Group N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), ...
Breaking Medicine Technology: